lypressin has been researched along with Acute-On-Chronic Liver Failure in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, R; Kulkarni, AV; Kumar, K; Premkumar, M; Rao, PN; Ravikumar, ST; Reddy, DN; Sharma, M; Tevethia, H | 1 |
| Curry, MP; Jamil, K; Pappas, SC; Reddy, KR; Sanyal, A; Vargas, H; Wong, F | 1 |
| Reiberger, T | 1 |
| Chen, G; Han, MF; Jiang, QQ; Kilonzo, SB; Ma, K; Ning, Q; Wan, XY; Wang, YL; Wu, WY; You, J | 1 |
| Agarwal, S; Gupta, S; Pandey, N; Singh, S; Verma, S | 1 |
| Anand, A | 1 |
| Gao, Y; Hou, B; Lin, S; Zhang, DD; Zhu, Y | 1 |
| Bhadoria, AS; Jindal, A; Maiwall, R; Sarin, SK | 1 |
| Ginès, P | 1 |
1 trial(s) available for lypressin and Acute-On-Chronic Liver Failure
| Article | Year |
|---|---|
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Albumins; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Respiratory Insufficiency; Terlipressin; Vasoconstrictor Agents | 2022 |
8 other study(ies) available for lypressin and Acute-On-Chronic Liver Failure
| Article | Year |
|---|---|
Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Hepatorenal Syndrome; Humans; Lypressin; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2022 |
When Should We Stop Treatment With Terlipressin and Albumin for Patients With Hepatorenal Syndrome?
Topics: Acute-On-Chronic Liver Failure; Albumins; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin | 2018 |
Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Biomarkers; Disease Progression; Female; Hepatitis B virus; Humans; Kidney Tubules; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Risk Factors; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2018 |
Letter To Editor: Terlipressin is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute On Chronic Liver Failure.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Humans; Lypressin; Norepinephrine; Terlipressin | 2018 |
Is Terlipressin Superior to Noradrenaline in the Treatment of Acute Kidney Injury in Acute-on-Chronic Liver Failure?
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Humans; Lypressin; Norepinephrine; Terlipressin | 2019 |
Letter to Editor: The Synergistic Effect of Albumin on Terlipressin in Acute-on-Chronic Liver Failure With Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Albumins; Humans; Lypressin; Norepinephrine; Terlipressin | 2019 |
Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; India; Lypressin; Male; Middle Aged; Peritonitis; Retrospective Studies; Severity of Illness Index; Survival Analysis; Terlipressin; Vasoconstrictor Agents | 2016 |
Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Terlipressin and Beyond.
Topics: Acute-On-Chronic Liver Failure; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin; Vasoconstrictor Agents | 2016 |